AMT Medical funding news – Netherlands-based AMT Medical Raises €22Million in Series B Round Funding

Apr 17, 2025 | By Startuprise

AMT Medical funding news - Netherlands-based AMT Medical Raises €22Million in Series B Round Funding

Netherlands-based AMT Medical has raised €22 million in Series B funding to speed up the development and launch of its heart bypass technology.

SUMMARY

  • Netherlands-based AMT Medical has raised €22 million in Series B funding to speed up the development and launch of its heart bypass technology.
  • AMT Medical, founded in 2015, is developing a new method for heart bypass surgery.

The round included a €5 million investment from Invest-NL, a Dutch investor that supports innovation. It was led by Bender Analytical Holding, with participation from Oost NL, the European Innovation Council (EIC), and other private investors.

Read also - EcoDataCenter funding news – EcoDataCenter Secures €450 Million in Funding

The funding from Invest-NL will help AMT Medical get CE certification, run clinical trials in the Netherlands and abroad, and get ready to enter the market.

This investment supports Invest-NL’s goal of making healthcare more affordable, accessible, and less dependent on staff.

About AMT Medical

AMT Medical, founded in 2015, is developing a new method for heart bypass surgery. Its Elana Heart Bypass technology allows doctors to perform the procedure without opening the chest or stopping the heart. Instead of stitches, it uses a special clip and laser to connect blood vessels.

The system works with surgical robots and enables consistent, less invasive surgeries. This makes it possible to treat more patients, including those who can't undergo traditional open-heart surgery.

Recommended Stories for You